New results on genetic techniques that are helping doctors diagnose and treat lung cancer were released at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) in Geneva, Switzerland. In one report (Abstract No. 81O; Friday 25th April, 16:30), Israeli researchers from Rosetta Genomics, a biotech company developing microRNA-based technologies for diagnostic and therapeutic applications, describe a test that helps make crucial distinctions between types of lung cancer. The researchers show the method can accurately distinguish between squamous and non-squamous forms of non-small-cell lung cancer based on the level...
Bookmark/Search this post with:
